Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_14375 | 163 | 3.40 | Mlig455_056945 | Neo: - Age: - |
Mlig455_056945 {REF} {Length: 1764} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=49.6]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=94.4, Expect=4e-22]} {RNA1509_48719} {RNA1310_16266.1} {RNA815_10544.2} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 2.521 | 1.902 | 0.32136 | 0.97063 | |
RegionR2 | 0.731 | 1.902 | 0.53349 | 0.90424 | |
RegionR3 | 0.588 | 1.902 | 0.53278 | 1.00000 | |
RegionR4 | -2.882 | 1.902 | 0.99993 | 1.00000 | |
RegionR5 | -3.101 | 1.902 | 1.00000 | 1.00000 | |
RegionR6 | -5.552 | 1.902 | 0.05083 | 0.42195 | |
RegionR7 | 3.028 | 1.902 | 0.04741 | 0.41837 | |
RegionR8 | 4.667 | 1.902 | 0.00493 | 0.12498 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -6.819 | 1.902 | 0.31504 | 1.00000 | |
RegenerationR2 | -1.113 | 1.902 | 0.61961 | 0.92326 | |
RegenerationR3 | -0.853 | 1.902 | 0.69353 | 0.94568 | |
RegenerationR4 | 1.33 | 1.902 | 0.58827 | 0.90820 | |
RegenerationR5 | -2.453 | 1.902 | 0.20750 | 0.64086 | |
RegenerationR6 | -0.729 | 1.902 | 1.00000 | 1.00000 | |
RegenerationBL | -5.85 | 1.902 | 1.00000 | 1.00000 | |
RegenerationTP | -3.297 | 1.902 | 0.21327 | 0.65636 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_14375 | 163 | 3.4 | Mlig455_056945 | Neo: - Age: - |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_056945 {REF} {Length: 1764} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=49.6]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=94.4, Expect=4e-22]} {RNA1509_48719} {RNA1310_16266.1} {RNA815_10544.2} | |
2. | MligTC455_19180 | 732 | 15.25 | Mlig455_065589 | Neo: - Age: - Region-enriched R8: 1.853/0.01583 |
3.444 | 0.722 | 0.796 | - | 0.978 | 0.948 | - | Mlig455_065589 {REF} {Length: 1480} {Smed: dd_Smed_v6_5147_0_1, dd_Smed_v6_5147_0_1, [RH, Score=62.0, Expect=4e-11]} {RNA1509_38428} {RNA1310_38164} {RNA815_17603} | |
3. | MligTC455_24113 | 417 | 8.68 | Mlig455_051239 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.866/0.00000 |
3.407 | - | - | 0.950 | 0.830 | 0.746 | 0.881 | Mlig455_051239 {REF} {Length: 4276} {NoTransDecoderORF} {RNA1509_23461} {RNA1310_60603} {RNA815_48925} | |
4. | MligTC455_40223 | 172 | 3.59 | Mlig455_016264 | Neo: - Age: - Region-enriched R8: 3.704/0.01076 |
CHRNA10 | 3.342 | 0.958 | 0.836 | - | - | 0.717 | 0.831 | Mlig455_016264 {REF} {Length: 4782} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=169.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=230, Expect=2e-68]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=225, Expect=1e-66]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=233, Expect=9e-70]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=236, Expect=2e-70]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=215, Expect=6e-63]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=280, Expect=9e-87]} {RNA1509_35668} {RNA1310_11720.1} {RNA815_6827} |
5. | MligTC455_44724 | 186 | 3.88 | Mlig455_024176 | Neo: - Age: - Region-enriched R7: 3.890/0.00870 |
2.799 | - | 0.860 | - | 0.964 | - | 0.975 | Mlig455_024176 {REF} {Length: 967} {RNA1310_84543} {RNA815_47586} | |
6. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 2.751 | 0.976 | 0.856 | - | - | 0.919 | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
7. | MligTC455_33071 | 1868 | 38.92 | Mlig455_026398, Mlig455_052608 | Neo: - Age: logFC(26M/2M)=0.243 Region-enriched R7: 1.622/0.00135 |
KCNN2 | 2.739 | - | 0.919 | - | 0.966 | 0.854 | - | Mlig455_026398 {REF} {Length: 4271} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=144.5]; Calmodulin binding domain [PF02888.18, score=76.5]; Ion channel [PF07885.18, score=58.3]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=402, Expect=2e-135]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=402, Expect=1e-133]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=396, Expect=1e-133]} {Mouse: ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=405, Expect=1e-134]; ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=403, Expect=9e-136]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=392, Expect=3e-132]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=392, Expect=3e-132]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=427, Expect=5e-146]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=338, Expect=5e-110]} {Smed: dd_Smed_v6_13309_0_1, dd_Smed_v6_13309_0_1, [RH, Score=491, Expect=2e-172]} {RNA1509_39770, RNA1509_8469} {RNA1310_12461.1, RNA1509_39770, RNA1509_8469} {RNA1509_39770, RNA1509_8469, RNA815_4092.1} Mlig455_052608 {REF} {Length: 4433} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=144.5]; Calmodulin binding domain [PF02888.18, score=76.5]; Ion channel [PF07885.18, score=58.3]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=402, Expect=2e-135]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=402, Expect=1e-133]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=396, Expect=1e-133]} {Mouse: ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=405, Expect=1e-134]; ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=403, Expect=9e-136]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=392, Expect=3e-132]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=392, Expect=3e-132]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=427, Expect=5e-146]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=338, Expect=5e-110]} {Smed: dd_Smed_v6_13309_0_1, dd_Smed_v6_13309_0_1, [RH, Score=491, Expect=2e-172]} {RNA1509_57498, RNA1509_8469} {RNA1310_12461.2, RNA1509_57498} {RNA1509_57498, RNA815_4092.1} |
8. | MligTC455_44725 | 67 | 1.4 | Mlig455_024194 | Neo: - Age: - |
2.708 | - | 0.805 | - | 0.949 | - | 0.954 | Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586} | |
9. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 2.683 | - | 0.866 | - | 0.991 | - | 0.826 | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
10. | MligTC455_48523 | 615 | 12.81 | Mlig455_027573 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.661 Region-enriched R2: 5.785/0.00008 |
2.651 | - | 0.857 | - | 0.956 | 0.838 | - | Mlig455_027573 {REF} {Length: 1106} {TRANSSPLICED} {Pfam: N-formylglutamate amidohydrolase [PF05013.14, score=30.2]} {RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1310_12591, RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1509_25119, RNA1509_35691, RNA1509_59740, RNA815_14574} | |
11. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
2.639 | - | 0.850 | - | 0.973 | - | 0.816 | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
12. | MligTC455_36372 | 925 | 19.28 | Mlig455_005680 | Neo: - Age: logFC(26M/2M)=2.101 Region-enriched R2: 7.233/0.00006 |
2.638 | - | 0.725 | - | 0.935 | 0.978 | - | Mlig455_005680 {REF} {Length: 1993} {RNA1509_18409, RNA1509_31432} {RNA1310_82233, RNA1509_18409, RNA1509_31432} {RNA1509_18409, RNA1509_31432, RNA815_42934} | |
13. | MligTC455_34233 | 101 | 2.11 | Mlig455_053145 | Neo: - Age: Down-Up-Down |
ACR | 2.629 | - | - | 0.864 | 0.807 | 0.958 | - | Mlig455_053145 {REF} {Length: 1245} {Pfam: Trypsin [PF00089.28, score=175.3]} {Human: ENSG00000100312, ACR, acrosin, [Score=161, Expect=1e-45]; ENSG00000283539, ACR, acrosin, [Score=161, Expect=1e-45]; ENSG00000122194, PLG, plasminogen, [Score=156, Expect=8e-42]; ENSG00000198670, LPA, lipoprotein(a), [Score=155, Expect=2e-41]; ENSG00000178297, TMPRSS9, transmembrane serine protease 9, [Score=154, Expect=3e-41]} {Mouse: ENSMUSG00000059481, Plg, plasminogen, [Score=152, Expect=1e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=151, Expect=4e-40]; ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=149, Expect=1e-39]; ENSMUSG00000033177, Tmprss7, transmembrane serine protease 7, [Score=145, Expect=4e-38]} {Dmel: FBgn0036287, CG10663, [Score=132, Expect=6e-34]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=125, Expect=2e-33]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [Score=175, Expect=3e-52]} {RNA1509_37786} {RNA1310_26421} {RNA815_13601} |
14. | MligTC455_25854 | 1015 | 21.15 | Mlig455_052672 | Neo: - Age: logFC(26M/2M)=-0.640 Region-specific R8: 3.800 Region-enriched R8: 3.703/0.00000 Regeneration-downregulated BL: -2.563 Regeneration-depleted BL: -2.563 |
2.626 | 0.974 | 0.700 | - | - | - | 0.952 | Mlig455_052672 {REF} {Length: 1364} {Pfam: PLAC8 family [PF04749.19, score=60.9]} {Smed: dd_Smed_v6_865_0_1, dd_Smed_v6_865_0_1, [Score=98.2, Expect=1e-26]} {RNA1509_58157} {RNA1310_24348, RNA1509_58157} {RNA1509_58157, RNA815_10637.1} | |
15. | MligTC455_44661 | 48 | 1 | Mlig455_038182 | Neo: - Age: logFC(26M/2M)=-0.564 |
ANO7 | 2.621 | - | 0.811 | - | 0.976 | 0.834 | - | Mlig455_038182 {REF} {Length: 3290} {Pfam: Calcium-activated chloride channel [PF04547.14, score=599.2]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=223.8]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=572, Expect=0.0]} {Dmel: FBgn0038721, subdued, [Score=422, Expect=3e-132]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=163, Expect=4e-41]} {Smed: dd_Smed_v6_19189_0_1, dd_Smed_v6_19189_0_1, [Score=670, Expect=0.0]} {RNA1509_46639} {RNA1310_1412.2} {RNA815_15650} |
16. | MligTC455_45987 | 1592 | 33.17 | Mlig455_024379, Mlig455_024495 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.664 Region-specific R8: 3.405 Region-enriched R8: 3.716/0.00000 Regeneration-depleted BL: -2.612 |
PKDREJ | 2.617 | 0.977 | - | - | - | 0.818 | 0.822 | Mlig455_024379 {REF} {Length: 9101} {Pfam: PKD domain [PF18911.2, score=34.9]; PKD domain [PF00801.22, score=21.5]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} Mlig455_024495 {REF} {Length: 8484} {Pfam: Polycystin cation channel [PF08016.14, score=333.9]; PLAT/LH2 domain [PF01477.25, score=69.5]; PKD domain [PF18911.2, score=32.8]; Ion transport protein [PF00520.33, score=31.6]; PKD domain [PF00801.22, score=19.8]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [RH, Score=346, Expect=8e-95]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [RH, Score=327, Expect=4e-89]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [RH, Score=319, Expect=7e-87]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=167, Expect=3e-41]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=198, Expect=3e-52]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=592, Expect=9e-172]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} |
17. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 2.605 | 0.751 | 0.856 | - | - | - | 0.998 | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
18. | MligTC455_41430 | 65 | 1.35 | Mlig455_070915 | Neo: - Age: - |
BHLHE22 | 2.583 | - | 0.816 | - | 0.982 | 0.785 | - | Mlig455_070915 {REF} {Length: 1052} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=58.4]} {Human: ENSG00000180828, BHLHE22, basic helix-loop-helix family member e22, [RH, Score=135, Expect=4e-37]} {Mouse: ENSMUSG00000025128, Bhlhe22, basic helix-loop-helix family, member e22, [RH, Score=133, Expect=8e-37]; ENSMUSG00000045493, Bhlhe23, basic helix-loop-helix family, member e23, [RH, Score=129, Expect=1e-36]} {Dmel: FBgn0032651, Oli, Olig family, [RH, Score=135, Expect=4e-39]} {Celegans: WBGene00001961, hlh-17, Helix Loop Helix, [RH, Score=103, Expect=2e-28]} {Smed: dd_Smed_v6_12722_0_1, dd_Smed_v6_12722_0_1, [RH, Score=129, Expect=2e-37]} {RNA1310_107478} |
19. | MligTC455_54034 | 260 | 5.41 | Mlig455_017202 | Neo: - Age: - Region-enriched R8: 2.476/0.02915 |
CALML3 | 2.583 | 0.720 | - | - | 0.966 | - | 0.897 | Mlig455_017202 {REF} {Length: 1789} {Pfam: EF hand [PF00036.34, score=86.0]; EF-hand domain pair [PF13499.8, score=75.1]; EF hand [PF13202.8, score=71.2]; EF-hand domain [PF13405.8, score=67.8]; EF-hand domain pair [PF13833.8, score=53.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.0]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=82.8, Expect=1e-20]; ENSG00000198668, CALM1, calmodulin 1, [Score=79.7, Expect=2e-19]; ENSG00000160014, CALM3, calmodulin 3, [Score=79.7, Expect=2e-19]; ENSG00000143933, CALM2, calmodulin 2, [Score=79.7, Expect=2e-19]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=81.6, Expect=3e-20]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=79.7, Expect=1e-19]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=79.7, Expect=1e-19]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=79.7, Expect=1e-19]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=77.8, Expect=6e-19]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=77.8, Expect=5e-19]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=77.8, Expect=4e-19]} {RNA1509_40737} {RNA1310_63281, RNA1509_40737} {RNA1509_40737, RNA815_19875} |
20. | MligTC455_25928 | 181 | 3.78 | Mlig455_006534, Mlig455_006538, Mlig455_006649, Mlig455_006700 | Neo: - Age: logFC(26M/2M)=-0.528 Region-specific R2: 7.256 Region-enriched R2: 5.788/0.02697 |
2.57 | - | - | 0.761 | 0.983 | 0.826 | - | Mlig455_006534 {REF} {Length: 689} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006538 {REF} {Length: 1691} {RNA1509_12380} {RNA1310_164.2} {RNA815_19957} Mlig455_006649 {REF} {Length: 829} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006700 {REF} {Length: 750} {RNA1509_22927} {RNA1310_81957.2} {RNA815_41771.2} |
|
21. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
2.57 | - | 0.822 | - | 0.951 | 0.797 | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
22. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
2.538 | - | 0.842 | - | 0.982 | 0.714 | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
23. | MligTC455_30159 | 107 | 2.22 | Mlig455_008465, Mlig455_009916 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.961/0.00498 |
TCF7L1 | 2.537 | - | 0.761 | 0.788 | 0.988 | - | - | Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690} Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690} |
24. | MligTC455_49925 | 1150 | 23.95 | Mlig455_064457 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.630 Region-enriched R2: 9.768/0.00000 |
2.532 | - | 0.710 | - | 0.867 | 0.955 | - | Mlig455_064457 {REF} {Length: 2074} {RNA1509_11575, RNA1509_47467, RNA1509_51886, RNA1509_59587} {RNA1310_82147.1, RNA1509_11575, RNA1509_47467, RNA1509_51886, RNA1509_59587} {RNA1509_11575, RNA1509_47467, RNA1509_51886, RNA1509_59587, RNA815_19226.1} | |
25. | MligTC455_17967 | 3579 | 74.57 | Mlig455_051723, Mlig455_051747 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.373 Region-enriched R2: 2.354/0.00024 |
2.521 | - | 0.786 | - | 0.955 | - | 0.780 | Mlig455_051723 {REF} {Length: 1123} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=33.4]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=21.7]; Protein of unknown function (DUF559) [PF04480.14, score=20.6]} {RNA1509_16925} {RNA1310_34603.1} {RNA815_20381} Mlig455_051747 {REF} {Length: 1166} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=36.0]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=25.9]; Protein of unknown function (DUF559) [PF04480.14, score=22.5]; REase_MTES_1575 [PF18741.3, score=20.8]; CW_7 repeat [PF08230.13, score=19.3]} {RNA1509_16925} {RNA1310_34603.1} {RNA815_20381} |
|
26. | MligTC455_34819 | 168 | 3.5 | Mlig455_010505, Mlig455_061873 | Neo: - Age: Up-Down-Down |
QRFPR | 2.519 | - | - | - | 0.822 | 0.970 | 0.727 | Mlig455_010505 {REF} {Length: 4092} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=158.0]; Olfactory receptor [PF13853.8, score=19.8]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [RH, Score=166, Expect=1e-45]} {Mouse: ENSMUSG00000029917, C130060K24Rik, RIKEN cDNA C130060K24 gene, [RH, Score=150, Expect=3e-40]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=137, Expect=2e-34]} {Celegans: WBGene00007635, npr-4, NeuroPeptide Receptor family, [Score=122, Expect=4e-30]} {Smed: dd_Smed_v6_22952_0_1, dd_Smed_v6_22952_0_1, [Score=194, Expect=4e-57]} {RNA1310_26846} {RNA815_28382} Mlig455_061873 {REF} {Length: 3092} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=131.2]; Olfactory receptor [PF13853.8, score=19.8]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=131, Expect=4e-33]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=115, Expect=1e-27]; ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [Score=112, Expect=4e-27]; ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=112, Expect=1e-26]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=112, Expect=5e-26]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=103, Expect=5e-24]} {Smed: dd_Smed_v6_22952_0_1, dd_Smed_v6_22952_0_1, [Score=162, Expect=4e-45]} {RNA1310_26846} {RNA815_28382} |
27. | MligTC455_41296 | 43 | 0.9 | Mlig455_021118 | Neo: - Age: - |
2.494 | - | 0.800 | - | 0.951 | 0.743 | - | Mlig455_021118 {REF} {Length: 2049} {RNA1509_59262} {RNA1310_31928} {RNA815_32415} | |
28. | MligTC455_25766 | 42 | 0.88 | Mlig455_008785, Mlig455_008821, Mlig455_008919 | Neo: - Age: - Region-enriched R2: 5.588/0.00166 |
2.49 | - | 0.700 | - | 0.982 | - | 0.808 | Mlig455_008785 {REF} {Length: 1744} {RNA1310_20437} {RNA815_15201} Mlig455_008821 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} Mlig455_008919 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} |
|
29. | MligTC455_41131 | 40 | 0.84 | Mlig455_042108 | Neo: - Age: - |
2.481 | - | - | - | 0.954 | 0.713 | 0.814 | Mlig455_042108 {REF} {Length: 1899} {Pfam: F5/8 type C domain [PF00754.27, score=36.7]} {Celegans: WBGene00015646, mlt-10, [Score=161, Expect=1e-44]} {RNA1310_54710.3} {RNA815_24559} | |
30. | MligTC455_17966 | 1490 | 31.04 | Mlig455_026737 | Neo: - Age: logFC(26M/2M)=-0.346 Region-specific R2: 3.759 Region-enriched R2: 2.729/0.00000 Regeneration-downregulated R6: -2.271 Regeneration-depleted R6: -2.271 |
2.48 | - | 0.777 | - | 0.951 | - | 0.752 | Mlig455_026737 {REF} {Length: 1222} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=36.3]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=26.5]; Protein of unknown function (DUF559) [PF04480.14, score=20.7]; REase_MTES_1575 [PF18741.3, score=20.0]} {RNA1509_18273} {RNA1310_34603.1} {RNA815_20381} | |
31. | MligTC455_31172 | 195 | 4.06 | Mlig455_028354 | Neo: - Age: - Region-enriched R5: 4.005/0.04475 |
2.46 | - | 0.790 | - | 0.950 | 0.720 | - | Mlig455_028354 {REF} {Length: 2036} {RNA1310_45498} {RNA815_15412} | |
32. | MligTC455_31345 | 102 | 2.12 | Mlig455_004435, Mlig455_004447 | Neo: - Age: - |
RTL1 | 2.432 | - | 0.737 | - | 0.969 | 0.726 | - | Mlig455_004435 {REF} {Length: 551} {RNA1310_70973} {RNA815_36768} Mlig455_004447 {REF} {Length: 2743} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=93.3]; Integrase zinc binding domain [PF17921.3, score=77.6]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=45.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=75.9, Expect=2e-13]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=255, Expect=1e-71]} {RNA1509_33330} {RNA1310_5975.2} {RNA815_11487} |
33. | MligTC455_04420 | 209 | 4.36 | Mlig455_005696 | Neo: - Age: - Region-enriched R7: 3.482/0.00030 |
2.412 | 0.961 | - | - | 0.712 | 0.739 | - | Mlig455_005696 {REF} {Length: 2113} {Pfam: Major Facilitator Superfamily [PF07690.18, score=68.2]; PUCC protein [PF03209.17, score=38.1]; MFS/sugar transport protein [PF13347.8, score=25.9]; MFS_1 like family [PF12832.9, score=24.5]} {Smed: dd_Smed_v6_8550_0_1, dd_Smed_v6_8550_0_1, [Score=388, Expect=2e-131]} {RNA1509_18256} {RNA1310_12968} {RNA815_5192} | |
34. | MligTC455_52491 | 413 | 8.61 | Mlig455_041906 | Neo: - Age: logFC(26M/2M)=-0.855 Region-specific R2: 3.229 Region-enriched R2: 2.944/0.00036 |
2.396 | - | 0.731 | - | 0.964 | 0.701 | - | Mlig455_041906 {REF} {Length: 712} {RNA1509_31700} {RNA1310_225.1, RNA1509_31700} {RNA1509_31700, RNA815_107.1} | |
35. | MligTC455_25921 | 329 | 6.86 | Mlig455_006703 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-2.996 Region-enriched R2: 6.614/0.00492 |
2.384 | - | 0.700 | 0.713 | 0.971 | - | - | Mlig455_006703 {REF} {Length: 664} {RNA1509_22927} {RNA1310_80445} {RNA815_41771.1} | |
36. | MligTC455_38796 | 1266 | 26.37 | Mlig455_060220, Mlig455_060235 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.521/0.00003 |
BACE1 | 1.989 | 0.992 | - | - | - | - | 0.997 | Mlig455_060220 {REF} {Length: 1841} {Pfam: Eukaryotic aspartyl protease [PF00026.25, score=72.8]; Xylanase inhibitor C-terminal [PF14541.8, score=19.9]} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=214, Expect=5e-63]} {Dmel: FBgn0032304, CG17134, [Score=56.2, Expect=3e-08]} {Celegans: WBGene00000218, asp-5, ASpartyl Protease, [Score=47.8, Expect=1e-05]} {RNA1509_48153} {RNA1310_17192, RNA1509_48153} {RNA1509_48153, RNA815_50706} Mlig455_060235 {REF} {Length: 1482} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=119, Expect=2e-29]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=118, Expect=1e-28]} {RNA1509_48153} {RNA1310_17192} {RNA815_51940} |
37. | MligTC455_21451 | 352 | 7.34 | Mlig455_040118, Mlig455_067333 | Neo: - Age: - Region-enriched R8: 6.038/0.00000 |
ANGPTL7 | 1.979 | 0.982 | - | - | - | - | 0.997 | Mlig455_040118 {REF} {Length: 1728} {tRNA: Val(CAC),pseudo, score=20.9} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.6]; PAN domain [PF00024.28, score=20.2]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=98.6, Expect=3e-23]; ENSG00000120332, TNN, tenascin N, [Score=98.2, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=96.7, Expect=5e-22]; ENSG00000116147, TNR, tenascin R, [Score=96.7, Expect=8e-22]; ENSG00000160339, FCN2, ficolin 2, [Score=94.0, Expect=5e-22]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=2e-22]; ENSMUSG00000015829, Tnr, tenascin R, [Score=97.8, Expect=2e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=95.9, Expect=5e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=2e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.0, Expect=8e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=9e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.2, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=100, Expect=8e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} Mlig455_067333 {REF} {Length: 1595} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=128.2]; PAN domain [PF00024.28, score=20.3]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=99.8, Expect=1e-23]; ENSG00000120332, TNN, tenascin N, [Score=99.0, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=98.2, Expect=2e-22]; ENSG00000116147, TNR, tenascin R, [Score=97.1, Expect=7e-22]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=98.2, Expect=2e-22]; ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=3e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=97.4, Expect=2e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=3e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.4, Expect=6e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=8e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.6, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=101, Expect=4e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} |
38. | MligTC455_13018 | 1993 | 41.51 | Mlig455_033923 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.482 Region-enriched R8: 5.842/0.00000 |
1.978 | 0.991 | - | - | - | - | 0.987 | Mlig455_033923 {REF} {Length: 1258} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1310_45334, RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130, RNA815_5573.2} | |
39. | MligTC455_03038 | 227 | 4.72 | Mlig455_060778 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.261/0.00000 |
1.975 | 0.985 | - | - | - | - | 0.990 | Mlig455_060778 {REF} {Length: 4155} {TRANSSPLICED} {tRNA: Val(CAC),pseudo, score=27.8} {Mouse: ENSMUSG00000059854, Hydin, HYDIN, axonemal central pair apparatus protein, [Score=55.1, Expect=5e-07]} {RNA1509_16236} {RNA1310_4008} {RNA815_2550} | |
40. | MligTC455_20781 | 5503 | 114.65 | Mlig455_066518 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.978 Region-enriched R8: 6.430/0.00000 |
FBN2 | 1.967 | 0.984 | - | - | - | - | 0.983 | Mlig455_066518 {REF} {Length: 6133} {Pfam: EGF domain [PF12947.9, score=539.9]; Calcium-binding EGF domain [PF07645.17, score=534.2]; Complement Clr-like EGF-like [PF12662.9, score=301.4]; EGF-like domain [PF00008.29, score=202.5]; Human growth factor-like EGF [PF12661.9, score=158.8]; MSP1 EGF domain 1 [PF12946.9, score=133.7]; Coagulation Factor Xa inhibitory site [PF14670.8, score=101.2]; Pvs28 EGF domain [PF06247.13, score=76.5]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=27.8]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=348, Expect=8e-98]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=350, Expect=2e-98]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-96]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=268, Expect=2e-72]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=426, Expect=1e-123]} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA1509_770} {RNA1310_1209, RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA815_317.1} |
41. | MligTC455_33475 | 168 | 3.5 | Mlig455_036879 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.551 Region-enriched R8: 7.210/0.00005 |
1.964 | 0.984 | - | - | - | - | 0.980 | Mlig455_036879 {REF} {Length: 2954} {RNA1509_20567} {RNA1310_1034.1} {RNA815_502.1} | |
42. | MligTC455_07961 | 191 | 3.98 | Mlig455_051526 | Neo: - Age: - Region-enriched R8: 7.862/0.00000 Regeneration-enriched R5: 7.080 |
1.954 | 0.991 | - | - | - | - | 0.963 | Mlig455_051526 {REF} {Length: 437} {RNA815_63444} | |
43. | MligTC455_31518 | 19118 | 398.29 | Mlig455_053864, Mlig455_053878 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=2.053 Region-enriched R8: 7.674/0.00000 |
PI16 | 1.952 | 0.959 | - | - | - | - | 0.993 | Mlig455_053864 {REF} {Length: 1794} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} Mlig455_053878 {REF} {Length: 1368} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
44. | MligTC455_31519 | 9556 | 199.07 | Mlig455_055347 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.365 Region-enriched R8: 7.870/0.00000 |
PI16 | 1.952 | 0.959 | - | - | - | - | 0.993 | Mlig455_055347 {REF} {Length: 1681} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.5]; Kringle domain [PF00051.20, score=52.7]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=84.3, Expect=2e-17]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=82.4, Expect=6e-17]} {Dmel: FBgn0038126, CG8483, [Score=97.4, Expect=2e-22]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.1, Expect=9e-12]} {Smed: dd_Smed_v6_433_0_1, dd_Smed_v6_433_0_1, [Score=111, Expect=3e-29]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
45. | MligTC455_31520 | 9547 | 198.9 | Mlig455_055402 | Neo: - Age: logFC(26M/2M)=-0.427 Region-enriched R8: 7.718/0.00000 |
PI16 | 1.952 | 0.959 | - | - | - | - | 0.993 | Mlig455_055402 {REF} {Length: 1363} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=27.4]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=69.3, Expect=4e-13]; ENSG00000173401, GLIPR1L1, GLIPR1 like 1, [Score=67.8, Expect=4e-13]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=71.2, Expect=7e-14]} {Dmel: FBgn0038126, CG8483, [Score=55.8, Expect=6e-09]} {Celegans: WBGene00009890, scl-9, SCP-Like extracellular protein, [Score=50.4, Expect=1e-07]} {Smed: dd_Smed_v6_924_0_2, dd_Smed_v6_924_0_2, [Score=87.0, Expect=1e-21]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
46. | MligTC455_48954 | 316 | 6.59 | Mlig455_000336, Mlig455_067936 | Neo: - Age: - Region-enriched R8: 6.016/0.00000 |
WNT2 | 1.952 | 0.960 | - | - | - | - | 0.992 | Mlig455_000336 {REF} {Length: 2268} {Pfam: wnt family [PF00110.21, score=150.7]} {Human: ENSG00000105989, WNT2, Wnt family member 2, [Score=94.4, Expect=1e-20]; ENSG00000162552, WNT4, Wnt family member 4, [Score=92.8, Expect=3e-20]} {Mouse: ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [Score=95.1, Expect=4e-21]; ENSMUSG00000036856, Wnt4, wingless-type MMTV integration site family, member 4, [Score=93.2, Expect=2e-20]} {Dmel: FBgn0010453, Wnt4, Wnt oncogene analog 4, [Score=75.5, Expect=3e-14]} {Celegans: WBGene00000857, cwn-1, [Score=95.5, Expect=2e-21]} {Smed: dd_Smed_v6_14391_0_1, dd_Smed_v6_14391_0_1, [RH, Score=137, Expect=4e-36]} {RNA1509_39977} {RNA1310_11459, RNA1509_39977} {RNA1509_39977, RNA815_18855} Mlig455_067936 {REF} {Length: 2361} {Pfam: wnt family [PF00110.21, score=149.2]} {Human: ENSG00000105989, WNT2, Wnt family member 2, [Score=96.7, Expect=2e-21]; ENSG00000162552, WNT4, Wnt family member 4, [Score=92.0, Expect=6e-20]} {Mouse: ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [Score=97.4, Expect=7e-22]} {Dmel: FBgn0010453, Wnt4, Wnt oncogene analog 4, [Score=75.5, Expect=3e-14]} {Celegans: WBGene00000857, cwn-1, [Score=96.3, Expect=1e-21]} {Smed: dd_Smed_v6_14391_0_1, dd_Smed_v6_14391_0_1, [RH, Score=133, Expect=7e-35]} {RNA1509_39977} {RNA1310_11459} {RNA815_18855} |
47. | MligTC455_33925 | 519 | 10.82 | Mlig455_020716, Mlig455_020784 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.564/0.00000 |
1.949 | 0.986 | - | - | - | - | 0.963 | Mlig455_020716 {REF} {Length: 1635} {Pfam: Amastin surface glycoprotein [PF07344.13, score=21.1]} {RNA1310_25321} {RNA815_36976} Mlig455_020784 {REF} {Length: 2274} {Pfam: Amastin surface glycoprotein [PF07344.13, score=22.1]} {RNA1310_25321} {RNA815_36976} |
|
48. | MligTC455_53279 | 2935 | 61.14 | Mlig455_017965 | Neo: - Age: Down-Up-Down Region-specific R8: 3.606 Region-enriched R8: 3.165/0.00000 Regeneration-downregulated BL: -2.902 Regeneration-depleted BL: -2.902 |
1.948 | 0.983 | - | - | - | - | 0.965 | Mlig455_017965 {REF} {Length: 1023} {RNA1509_20769, RNA1509_34269} {RNA1310_44808, RNA1509_20769, RNA1509_34269} {RNA1509_20769, RNA1509_34269, RNA815_8213} | |
49. | MligTC455_53813 | 46 | 0.96 | Mlig455_038036 | Neo: - Age: Down-Down-Up |
1.947 | - | - | - | 0.985 | 0.962 | - | Mlig455_038036 {REF} {Length: 1511} {Smed: dd_Smed_v6_12148_0_3, dd_Smed_v6_12148_0_3, [Score=70.5, Expect=9e-14]} {RNA1310_21968} {RNA815_20437} | |
50. | MligTC455_36259 | 270 | 5.63 | Mlig455_012889 | Neo: - Age: - Region-enriched R8: 5.567/0.00000 Regeneration-depleted R6: -6.631 |
WNT7B | 1.945 | 0.947 | - | - | - | - | 0.998 | Mlig455_012889 {REF} {Length: 1741} {Pfam: wnt family [PF00110.21, score=249.8]} {Human: ENSG00000188064, WNT7B, Wnt family member 7B, [Score=153, Expect=3e-42]; ENSG00000105989, WNT2, Wnt family member 2, [Score=149, Expect=2e-40]; ENSG00000002745, WNT16, Wnt family member 16, [Score=147, Expect=1e-39]; ENSG00000154764, WNT7A, Wnt family member 7A, [Score=147, Expect=9e-40]} {Mouse: ENSMUSG00000029671, Wnt16, wingless-type MMTV integration site family, member 16, [Score=155, Expect=5e-43]; ENSMUSG00000022382, Wnt7b, wingless-type MMTV integration site family, member 7B, [Score=152, Expect=4e-42]; ENSMUSG00000022996, Wnt10b, wingless-type MMTV integration site family, member 10B, [Score=150, Expect=7e-41]} {Dmel: FBgn0284084, wg, wingless, [Score=133, Expect=4e-34]} {Celegans: WBGene00001188, egl-20, Wnt homolog, [Score=130, Expect=6e-34]} {Smed: dd_Smed_v6_28398_0_1, dd_Smed_v6_28398_0_1, [Score=214, Expect=3e-65]} {RNA1509_58183} {RNA1310_17932, RNA1509_58183} {RNA1509_58183, RNA815_30269} |
51. | MligTC455_22921 | 848 | 17.66 | Mlig455_048030 | Neo: - Age: - Region-enriched R8: 6.496/0.00000 Regeneration-downregulated BL: -8.561 Regeneration-depleted BL: -8.561 |
CNTNAP1 | 1.939 | 0.961 | - | - | - | - | 0.978 | Mlig455_048030 {REF} {Length: 2506} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=31.2]; Spondin-like TSP1 domain [PF19028.2, score=23.9]; Thrombospondin type 1 domain [PF19030.2, score=20.8]} {Human: ENSG00000108797, CNTNAP1, contactin associated protein 1, [Score=65.5, Expect=3e-11]} {Mouse: ENSMUSG00000017167, Cntnap1, contactin associated protein-like 1, [Score=69.3, Expect=1e-12]} {Dmel: FBgn0013997, Nrx-IV, Neurexin IV, [Score=63.5, Expect=6e-11]} {Celegans: WBGene00003772, nlr-1, Neurexin Like receptor, [Score=60.8, Expect=3e-10]} {Smed: dd_Smed_v6_2622_0_1, dd_Smed_v6_2622_0_1, [Score=70.5, Expect=2e-13]} {RNA1509_12135} {RNA1310_13292} {RNA815_6015.1} |
52. | MligTC455_20780 | 8892 | 185.26 | Mlig455_040314 | Neo: - Age: logFC(26M/2M)=-1.054 Region-enriched R8: 6.072/0.00000 |
NOTCH2 | 1.938 | 0.978 | - | - | - | - | 0.960 | Mlig455_040314 {REF} {Length: 15786} {Pfam: EGF domain [PF12947.9, score=500.6]; Calcium-binding EGF domain [PF07645.17, score=489.8]; Complement Clr-like EGF-like [PF12662.9, score=268.7]; EGF-like domain [PF00008.29, score=175.9]; Human growth factor-like EGF [PF12661.9, score=135.4]; MSP1 EGF domain 1 [PF12946.9, score=91.5]; von Willebrand factor type D domain [PF00094.27, score=75.8]; Coagulation Factor Xa inhibitory site [PF14670.8, score=51.8]; Pvs28 EGF domain [PF06247.13, score=34.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=25.7]} {Human: ENSG00000134250, NOTCH2, notch 2, [Score=246, Expect=4e-64]; ENSG00000138829, FBN2, fibrillin 2, [Score=237, Expect=3e-61]} {Mouse: ENSMUSG00000027878, Notch2, notch 2, [Score=249, Expect=6e-65]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-93]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=254, Expect=5e-67]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=415, Expect=3e-115]} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_770, RNA1509_9237} {RNA1310_1209, RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237, RNA815_317.1} |
53. | MligTC455_44435 | 628 | 13.08 | Mlig455_062382, Mlig455_062409 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.421 Region-enriched R8: 5.635/0.00000 |
DDI2, HMCN1 | 1.936 | 0.993 | - | - | - | - | 0.943 | Mlig455_062382 {REF} {Length: 12544} {TRANSSPLICED} {Pfam: Aspartyl protease [PF09668.12, score=182.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=76.1]; Thrombospondin type 1 domain [PF00090.21, score=72.3]; Spondin-like TSP1 domain [PF19028.2, score=68.4]; Arginine repressor, C-terminal domain [PF02863.20, score=43.6]; Aspartyl protease [PF13650.8, score=34.4]; Putative vacuolating cytotoxin [PF03077.16, score=29.0]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=26.1]; Thrombospondin type 1 domain [PF19030.2, score=23.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=22.2]; Retroviral aspartyl protease [PF00077.22, score=19.1]} {Human: ENSG00000197312, DDI2, DNA damage inducible 1 homolog 2, [Score=279, Expect=2e-82]} {Mouse: ENSMUSG00000078515, Ddi2, DNA-damage inducible protein 2, [Score=266, Expect=5e-78]; ENSMUSG00000047619, Ddi1, DNA-damage inducible 1, [Score=255, Expect=4e-74]} {Dmel: FBgn0030753, rngo, rings lost, [Score=275, Expect=1e-80]} {Celegans: WBGene00015308, ddi-1, Dna (DNA) Damage Inducible homolog, [Score=131, Expect=5e-32]} {Smed: dd_Smed_v6_2764_0_1, dd_Smed_v6_2764_0_1, [Score=213, Expect=1e-60]} {RNA1509_6950} {RNA1310_548} {RNA815_300} Mlig455_062409 {REF} {Length: 19342} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=78.9]; Thrombospondin type 1 domain [PF00090.21, score=74.6]; Arginine repressor, C-terminal domain [PF02863.20, score=41.0]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=32.2]; Putative vacuolating cytotoxin [PF03077.16, score=30.3]; Thrombospondin type 1 domain [PF19030.2, score=23.2]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=90.1, Expect=7e-17]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=90.5, Expect=4e-17]} {Dmel: FBgn0050046, CG30046, [Score=52.4, Expect=8e-06]} {Celegans: WBGene00000083, adt-2, ADAMTS family; ADAMTS-like protease, [Score=87.8, Expect=1e-16]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=159, Expect=6e-39]} {RNA1509_21415, RNA1509_6950} {RNA1310_548, RNA1509_21415, RNA1509_6950} {RNA1509_21415, RNA1509_6950, RNA815_300} |
54. | MligTC455_20404 | 2355 | 49.05 | Mlig455_053980 | Neo: - Age: - Region-enriched R7: 4.495/0.00000 Regeneration-downregulated BL: -4.662 Regeneration-depleted BL: -4.662 |
1.929 | 0.947 | - | - | - | - | 0.982 | Mlig455_053980 {REF} {Length: 505} {NoTransDecoderORF} {RNA1509_5548} {RNA1310_94516} {RNA815_53532} | |
55. | MligTC455_20400 | 4609 | 96.03 | Mlig455_007551, Mlig455_011814 | Neo: - Age: Up-Up-Up, logFC(26M/2M)=1.242 Region-enriched R7: 5.211/0.00000 Regeneration-downregulated BL: -6.608 Regeneration-depleted BL: -6.608 |
1.926 | 0.948 | - | - | - | - | 0.978 | Mlig455_007551 {REF} {Length: 486} {RNA1509_8862} {RNA1310_107754, RNA1509_8862} {RNA1509_8862, RNA815_47935} Mlig455_011814 {REF} {Length: 367} {RNA1509_8862} {RNA1310_107754} {RNA815_47935} |
|
56. | MligTC455_04474 | 114 | 2.37 | Mlig455_039605 | Neo: - Age: logFC(26M/2M)=-0.389 Region-enriched R8: 5.608/0.00012 |
HMCN1 | 1.925 | 0.960 | - | - | - | - | 0.965 | Mlig455_039605 {REF} {Length: 4319} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=405.5]; Spondin-like TSP1 domain [PF19028.2, score=340.3]; Thrombospondin type 1 domain [PF19030.2, score=125.1]; Scavenger receptor cysteine-rich domain [PF00530.20, score=57.7]; CCN3 Nov like TSP1 domain [PF19035.2, score=48.4]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=292, Expect=4e-80]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=288, Expect=7e-79]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=156, Expect=3e-38]} {Celegans: WBGene00016468, C36B7.5, [RH, Score=199, Expect=7e-52]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=264, Expect=9e-72]} {RNA1509_12135} {RNA1310_3277, RNA1509_12135} {RNA1509_12135, RNA815_5276} |
57. | MligTC455_16781 | 32 | 0.67 | Mlig455_003020, Mlig455_003313 | Neo: - Age: - |
1.925 | - | - | - | 0.943 | 0.982 | - | Mlig455_003020 {REF} {Length: 518} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=26.8]} {RNA1310_57787} {RNA815_49158} Mlig455_003313 {REF} {Length: 905} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=74.4]} {RNA1310_57787} {RNA815_49158} |
|
58. | MligTC455_36373 | 2360 | 49.17 | Mlig455_008690 | Neo: - Age: - Region-enriched R2: 7.147/0.00000 |
1.922 | - | - | - | 0.959 | 0.963 | - | Mlig455_008690 {REF} {Length: 1552} {RNA1509_2189} {RNA1310_71597} {RNA815_31926.1} | |
59. | MligTC455_06773 | 251 | 5.23 | Mlig455_069732 | Neo: - Age: Down-Up-Down |
1.919 | 0.920 | - | - | - | - | 0.999 | Mlig455_069732 {REF} {Length: 1347} {RNA1310_24767.1} {RNA815_33473} | |
60. | MligTC455_31114 | 53 | 1.1 | Mlig455_017272 | Neo: - |
SLC10A2 | 1.919 | - | - | - | - | 0.980 | 0.939 | Mlig455_017272 {REF} {Length: 2348} {Pfam: Sodium Bile acid symporter family [PF01758.18, score=113.6]; SBF-like CPA transporter family (DUF4137) [PF13593.8, score=38.7]} {Human: ENSG00000125255, SLC10A2, solute carrier family 10 member 2, [RH, Score=145, Expect=7e-39]} {Mouse: ENSMUSG00000023073, Slc10a2, solute carrier family 10, member 2, [RH, Score=155, Expect=7e-43]} {Dmel: FBgn0030638, CG11655, [Score=157, Expect=7e-43]} {Celegans: WBGene00044650, Y71G10AR.4, [Score=180, Expect=9e-51]} {Smed: dd_Smed_v6_14676_0_1, dd_Smed_v6_14676_0_1, [Score=260, Expect=5e-82]} {RNA1509_52848} {RNA1310_31875.1} {RNA815_14501} |
61. | MligTC455_48650 | 8593 | 179.02 | Mlig455_043924 | Neo: - Age: logFC(26M/2M)=-0.454 Region-enriched R8: 6.377/0.00000 |
1.918 | 0.970 | - | - | - | - | 0.948 | Mlig455_043924 {REF} {Length: 1776} {RNA1509_3829} {RNA1310_39915.1, RNA1509_3829} {RNA1509_3829, RNA815_21876} | |
62. | MligTC455_06772 | 238 | 4.96 | Mlig455_048772 | Neo: - Age: - Region-enriched R8: 6.268/0.00000 |
1.917 | 0.917 | - | - | - | - | 1.000 | Mlig455_048772 {REF} {Length: 839} {RNA1310_24767.2} {RNA815_33473} | |
63. | MligTC455_20401 | 11443 | 238.4 | Mlig455_013098, Mlig455_013191 | Neo: - Age: Up-Down-Up Region-enriched R7: 5.239/0.00000 Regeneration-downregulated BL: -6.183 Regeneration-depleted BL: -6.183 |
1.916 | 0.954 | - | - | - | - | 0.962 | Mlig455_013098 {REF} {Length: 379} {RNA1509_2705} {RNA1310_107754} {RNA815_47935} Mlig455_013191 {REF} {Length: 379} {RNA1509_2705} {RNA1310_107754} {RNA815_47935} |
|
64. | MligTC455_06181 | 524 | 10.92 | Mlig455_030220, Mlig455_067996 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.634/0.00000 |
1.914 | 0.948 | - | - | - | - | 0.966 | Mlig455_030220 {REF} {Length: 1310} {Pfam: Spt20 family [PF12090.10, score=21.7]} {RNA1310_56165} {RNA815_14421} Mlig455_067996 {REF} {Length: 1307} {RNA1310_56165} {RNA815_14421} |
|
65. | MligTC455_46202 | 1182 | 24.63 | Mlig455_015525 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.090 Region-enriched R7: 3.843/0.00000 Regeneration-downregulated BL: -3.302 Regeneration-depleted BL: -3.302 |
1.911 | 0.916 | - | - | - | - | 0.995 | Mlig455_015525 {REF} {Length: 2230} {RNA1509_26726, RNA1509_40578, RNA1509_41769, RNA1509_55570} {RNA1310_31635.1, RNA1509_26726, RNA1509_40578, RNA1509_41769, RNA1509_55570} {RNA1509_26726, RNA1509_40578, RNA1509_41769, RNA1509_55570, RNA815_27083.1} | |
66. | MligTC455_12388 | 25 | 0.52 | Mlig455_000936 | Neo: - Age: - |
SETMAR | 1.909 | - | - | - | 0.948 | 0.961 | - | Mlig455_000936 {REF} {Length: 2242} {Pfam: Transposase (partial DDE domain) [PF01359.20, score=48.4]; DDE superfamily endonuclease [PF13358.8, score=29.0]; Homeodomain-like domain [PF13565.8, score=24.2]; Transposase [PF01498.20, score=21.1]; Winged helix-turn helix [PF13551.8, score=19.9]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=167, Expect=3e-45]} {Smed: dd_Smed_v6_52102_0_1, dd_Smed_v6_52102_0_1, [Score=69.7, Expect=1e-14]} {RNA1310_28836.1} {RNA815_34045} |
67. | MligTC455_41805 | 2256 | 47 | Mlig455_015764, Mlig455_049489 | Neo: - Age: - Region-specific R8: 2.792 Region-enriched R8: 2.927/0.00000 |
PKD2 | 1.902 | 0.976 | - | - | - | - | 0.926 | Mlig455_015764 {REF} {Length: 3347} {Pfam: Polycystin cation channel [PF08016.14, score=395.7]; Ion transport protein [PF00520.33, score=60.8]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=618, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=617, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=255, Expect=3e-72]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=338, Expect=2e-104]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=660, Expect=0.0]} {RNA1509_31010} {RNA1310_4653.2} {RNA815_18688} Mlig455_049489 {REF} {Length: 3379} {Pfam: Polycystin cation channel [PF08016.14, score=493.3]; Ion transport protein [PF00520.33, score=89.5]; EF hand [PF00036.34, score=27.1]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]; EF-hand domain [PF13405.8, score=18.5]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=716, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=711, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=1e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=739, Expect=0.0]} {RNA1509_31010, RNA1509_51627} {RNA1310_4653.1, RNA1509_31010, RNA1509_51627} {RNA1509_31010, RNA1509_51627, RNA815_4316} |
68. | MligTC455_39971 | 147 | 3.07 | Mlig455_034549 | Neo: - Age: - Region-enriched R8: 4.475/0.00030 |
1.901 | 0.992 | - | - | - | - | 0.909 | Mlig455_034549 {REF} {Length: 2181} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {RNA1310_27858} {RNA815_17949} | |
69. | MligTC455_20407 | 5467 | 113.89 | Mlig455_054055 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.662 Region-enriched R7: 3.793/0.00000 Regeneration-downregulated BL: -5.435 Regeneration-depleted BL: -5.435 |
1.9 | 0.949 | - | - | - | - | 0.951 | Mlig455_054055 {REF} {Length: 1179} {RNA1509_40983} {RNA1310_94516} {RNA815_53532} | |
70. | MligTC455_30850 | 34 | 0.71 | Mlig455_019341, Mlig455_019556 | Neo: - Age: logFC(26M/2M)=-0.625 |
GRIK2, GRIK4 | 1.9 | 0.942 | - | - | - | - | 0.958 | Mlig455_019341 {REF} {Length: 3886} {Pfam: Ligand-gated ion channel [PF00060.28, score=95.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.6]; Receptor family ligand binding region [PF01094.30, score=53.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=22.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=160, Expect=8e-40]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=157, Expect=6e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=152, Expect=3e-37]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=160, Expect=4e-40]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=155, Expect=2e-38]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=153, Expect=6e-38]} {Dmel: FBgn0039927, CG11155, [Score=179, Expect=3e-46]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=257, Expect=5e-78]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} Mlig455_019556 {REF} {Length: 4135} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.5]; Receptor family ligand binding region [PF01094.30, score=39.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=19.4]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=155, Expect=3e-38]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=8e-37]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=154, Expect=5e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=149, Expect=1e-36]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=149, Expect=1e-36]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=147, Expect=4e-36]} {Dmel: FBgn0039927, CG11155, [Score=169, Expect=3e-43]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=259, Expect=1e-78]} {RNA1509_10728} {RNA1310_31364} {RNA815_8415.1} |
71. | MligTC455_14757 | 726 | 15.12 | Mlig455_043399, Mlig455_043416, Mlig455_043559, Mlig455_043567 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.347 Region-specific R8: 6.849 Region-enriched R8: 6.705/0.00000 Regeneration-downregulated BL: -8.524 Regeneration-depleted BL: -8.524 |
1.899 | 0.920 | - | - | - | - | 0.979 | Mlig455_043399 {REF} {Length: 5997} {Dmel: FBgn0010434, cora, coracle, [Score=80.5, Expect=1e-14]} {RNA1509_17394} {RNA1310_20597} {RNA815_24724} Mlig455_043416 {REF} {Length: 6138} {RNA1509_17394} {RNA1310_20597} {RNA815_24724} Mlig455_043559 {REF} {Length: 7159} {RNA1509_17394} {RNA1310_38694} {RNA815_21047} Mlig455_043567 {REF} {Length: 8454} {Dmel: FBgn0010434, cora, coracle, [Score=51.6, Expect=3e-06]} {RNA1509_17394} {RNA1310_20597} {RNA815_24724} |
|
72. | MligTC455_17039 | 24 | 0.5 | Mlig455_025016 | Neo: - Age: - |
1.899 | - | - | - | 0.930 | 0.969 | - | Mlig455_025016 {REF} {Length: 2009} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.8]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [RH, Score=209, Expect=1e-63]} {RNA1310_42205} {RNA815_15017} | |
73. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 1.898 | - | - | 0.940 | 0.958 | - | - | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
74. | MligTC455_13746 | 200 | 4.17 | Mlig455_064975, Mlig455_066810 | Neo: - Age: - Region-enriched R8: 8.067/0.00000 |
1.895 | 0.906 | - | - | - | - | 0.989 | Mlig455_064975 {REF} {Length: 2922} {RNA1509_22976} {RNA1310_9502} {RNA815_8881} Mlig455_066810 {REF} {Length: 2922} {RNA1509_22976} {RNA1310_9502} {RNA815_8881} |
|
75. | MligTC455_39644 | 439 | 9.15 | Mlig455_013029 | Neo: - Age: logFC(26M/2M)=1.036 Region-enriched R7: 6.439/0.00000 |
1.895 | 0.901 | - | - | - | - | 0.994 | Mlig455_013029 {REF} {Length: 544} {RNA1509_2705} {RNA1310_83617} {RNA815_52032} | |
76. | MligTC455_37220 | 580 | 12.09 | Mlig455_052567, Mlig455_065350 | Neo: - Age: - Region-enriched R8: 7.789/0.00000 |
FMNL1, FMNL3 | 1.894 | 0.897 | - | - | - | - | 0.997 | Mlig455_052567 {REF} {Length: 3222} {Pfam: Formin Homology 2 Domain [PF02181.25, score=164.8]} {Human: ENSG00000161791, FMNL3, formin like 3, [Score=115, Expect=2e-25]; ENSG00000184922, FMNL1, formin like 1, [Score=113, Expect=4e-25]; ENSG00000157827, FMNL2, formin like 2, [Score=112, Expect=1e-24]} {Mouse: ENSMUSG00000055805, Fmnl1, formin-like 1, [Score=121, Expect=1e-27]; ENSMUSG00000023008, Fmnl3, formin-like 3, [Score=118, Expect=2e-26]} {Dmel: FBgn0267795, Frl, Formin-like, [Score=101, Expect=2e-21]} {Celegans: WBGene00021698, frl-1, FRL (Formin Related gene in Leukocytes) homolog, [Score=84.7, Expect=2e-16]} {Smed: dd_Smed_v6_3917_0_2, dd_Smed_v6_3917_0_2, [Score=79.0, Expect=8e-15]} {RNA1509_29857, RNA1509_51590} {RNA1310_4919, RNA1509_29857, RNA1509_51590} {RNA1509_29857, RNA1509_51590, RNA815_9351} Mlig455_065350 {REF} {Length: 3132} {Pfam: Formin Homology 2 Domain [PF02181.25, score=113.1]} {Human: ENSG00000184922, FMNL1, formin like 1, [Score=84.7, Expect=9e-18]; ENSG00000157827, FMNL2, formin like 2, [Score=84.0, Expect=2e-17]; ENSG00000161791, FMNL3, formin like 3, [Score=83.2, Expect=5e-17]} {Mouse: ENSMUSG00000055805, Fmnl1, formin-like 1, [Score=93.6, Expect=1e-20]} {Dmel: FBgn0025641, DAAM, Dishevelled Associated Activator of Morphogenesis, [Score=67.8, Expect=3e-12]} {Smed: dd_Smed_v6_2533_0_1, dd_Smed_v6_2533_0_1, [Score=56.6, Expect=9e-09]} {RNA1509_51590} {RNA1310_4919} {RNA815_16059} |
77. | MligTC455_54305 | 43 | 0.89 | Mlig455_035878, Mlig455_035917 | Neo: - Age: - |
ZC3H10 | 1.888 | - | - | - | 0.921 | - | 0.967 | Mlig455_035878 {REF} {Length: 2474} {tRNA: Val(CAC),pseudo, score=28.9} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} Mlig455_035917 {REF} {Length: 2428} {tRNA: Val(CAC),pseudo, score=30.2} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} |
78. | MligTC455_36052 | 35640 | 742.5 | Mlig455_029280, Mlig455_058880 | Neo: - Age: Down-Up-Up Region-enriched R8: 7.655/0.00000 Regeneration-downregulated BL: -5.564 Regeneration-depleted BL: -5.564 |
1.887 | 0.898 | - | - | - | - | 0.989 | Mlig455_029280 {REF} {Length: 490} {RNA1509_8306} {RNA1310_81421} {RNA815_9196} Mlig455_058880 {REF} {Length: 1197} {RNA1509_28223, RNA1509_4978, RNA1509_8306} {RNA1310_81421, RNA1509_28223, RNA1509_4978, RNA1509_8306} {RNA1509_28223, RNA1509_4978, RNA1509_8306, RNA815_9196} |
|
79. | MligTC455_48757 | 61 | 1.28 | Mlig455_008828, Mlig455_008932 | Neo: - Age: Up-Down-Up |
DDC | 1.882 | - | - | - | 0.917 | 0.965 | - | Mlig455_008828 {REF} {Length: 2057} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=471.9]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=572, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=558, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=553, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_37174} {RNA815_42090} Mlig455_008932 {REF} {Length: 2145} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=470.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=574, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=559, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=554, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=564, Expect=0.0]} {RNA1310_37174} {RNA815_42090} |
80. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
1.881 | - | - | - | 0.987 | 0.894 | - | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
81. | MligTC455_51024 | 78 | 1.63 | Mlig455_042673 | Neo: - Age: - Region-enriched R8: 6.900/0.00001 |
1.875 | 0.877 | - | - | - | - | 0.998 | Mlig455_042673 {REF} {Length: 1953} {RNA1310_20305} {RNA815_32236} | |
82. | MligTC455_14752 | 17 | 0.36 | Mlig455_009102 | Neo: - Age: - |
1.874 | - | - | - | 0.921 | 0.953 | - | Mlig455_009102 {REF} {Length: 1690} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=50.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=89.7, Expect=1e-19]} {RNA1509_4484} {RNA1310_25467} {RNA815_39314} | |
83. | MligTC455_53480 | 31 | 0.64 | Mlig455_043390, Mlig455_043414, Mlig455_043557 | Neo: - Age: - |
WSCD2 | 1.874 | - | - | - | 0.971 | - | 0.903 | Mlig455_043390 {REF} {Length: 1215} {Pfam: WSC domain [PF01822.21, score=50.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=2e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=59.7, Expect=2e-10]} {RNA1310_30552} {RNA815_18175} Mlig455_043414 {REF} {Length: 1144} {Pfam: WSC domain [PF01822.21, score=46.1]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=56.2, Expect=8e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=57.4, Expect=3e-09]} {RNA1310_30552} {RNA815_18175} Mlig455_043557 {REF} {Length: 1209} {Pfam: WSC domain [PF01822.21, score=32.4]} {RNA1310_30552} {RNA815_18175} |
84. | MligTC455_15983 | 668 | 13.92 | Mlig455_018780, Mlig455_018950 | Neo: - Age: Up-Down-Down Region-enriched R8: 4.299/0.00000 |
1.872 | 0.962 | - | - | - | - | 0.910 | Mlig455_018780 {REF} {Length: 1496} {RNA1509_47436} {RNA1310_22809.1} {RNA815_49713} Mlig455_018950 {REF} {Length: 1264} {RNA1509_47436} {RNA1310_22809.1, RNA1509_47436} {RNA1509_47436, RNA815_49713} |
|
85. | MligTC455_06328 | 144 | 3 | Mlig455_044820 | Neo: - Age: Down-Down-Up Region-enriched R8: 2.752/0.01310 Regeneration-downregulated BL: -7.394 Regeneration-depleted BL: -7.394 |
NOTCH4 | 1.868 | 0.910 | - | - | - | - | 0.958 | Mlig455_044820 {REF} {Length: 2669} {TRANSSPLICED} {Pfam: EGF-like domain [PF00008.29, score=37.2]; Human growth factor-like EGF [PF12661.9, score=29.7]; EGF-like domain [PF07974.15, score=19.8]} {Human: ENSG00000234876, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000204301, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000235396, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000223355, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000206312, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000232339, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000165124, SVEP1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=104, Expect=3e-22]} {Mouse: ENSMUSG00000026923, Notch1, notch 1, [Score=92.4, Expect=1e-18]; ENSMUSG00000027878, Notch2, notch 2, [Score=90.1, Expect=6e-18]; ENSMUSG00000025020, Slit1, slit guidance ligand 1, [Score=89.7, Expect=7e-18]} {Dmel: FBgn0051665, wry, weary, [Score=115, Expect=3e-26]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=84.0, Expect=3e-16]} {Smed: dd_Smed_v6_7067_0_1, dd_Smed_v6_7067_0_1, [Score=107, Expect=1e-23]} {RNA1509_13430} {RNA1310_7596.1} {RNA815_13746} |
86. | MligTC455_17376 | 103 | 2.15 | Mlig455_020346 | Neo: - Age: - |
1.868 | - | - | 0.957 | - | - | 0.911 | Mlig455_020346 {REF} {Length: 1093} {NoTransDecoderORF} {RNA1310_106511} | |
87. | MligTC455_37748 | 123 | 2.56 | Mlig455_012702, Mlig455_033010 | Neo: - Age: - |
1.868 | 0.887 | - | - | 0.981 | - | - | Mlig455_012702 {REF} {Length: 2807} {Smed: dd_Smed_v6_32414_0_1, dd_Smed_v6_32414_0_1, [Score=87.0, Expect=4e-18]} {RNA1509_52343} {RNA1310_5679} {RNA815_10252} Mlig455_033010 {REF} {Length: 3464} {Smed: dd_Smed_v6_13730_0_1, dd_Smed_v6_13730_0_1, [Score=174, Expect=4e-45]} {RNA1509_52343} {RNA1310_5679} {RNA815_10252} |
|
88. | MligTC455_38699 | 267 | 5.56 | Mlig455_054929 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.183/0.01222 |
COLEC10 | 1.866 | - | - | - | 0.964 | 0.902 | - | Mlig455_054929 {REF} {Length: 1403} {Pfam: Lectin C-type domain [PF00059.23, score=45.4]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
89. | MligTC455_39972 | 142 | 2.96 | Mlig455_064814 | Neo: - Age: - Region-enriched R8: 4.539/0.00054 |
1.864 | 0.992 | - | - | - | - | 0.872 | Mlig455_064814 {REF} {Length: 2232} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=34.6]} {RNA1310_27858} {RNA815_17949} | |
90. | MligTC455_44219 | 289 | 6.02 | Mlig455_053855 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.323 Region-enriched R8: 2.811/0.00017 |
CDH23 | 1.864 | 0.901 | - | - | - | - | 0.963 | Mlig455_053855 {REF} {Length: 9181} {Pfam: Cadherin domain [PF00028.19, score=457.3]; Cadherin-like [PF08266.14, score=40.7]} {Human: ENSG00000107736, CDH23, cadherin related 23, [Score=538, Expect=6e-156]} {Mouse: ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=536, Expect=9e-156]} {Dmel: FBgn0038247, Cad88C, Cadherin 88C, [RH, Score=635, Expect=0.0]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=240, Expect=3e-63]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [RH, Score=749, Expect=0.0]} {RNA1509_10347} {RNA1310_449.1} {RNA815_181} |
91. | MligTC455_13310 | 59 | 1.22 | Mlig455_014368 | Neo: - Age: - |
1.862 | 0.864 | - | - | - | - | 0.998 | Mlig455_014368 {REF} {Length: 1243} {RNA1310_136830} | |
92. | MligTC455_54115 | 1122 | 23.38 | Mlig455_046735, Mlig455_046741, Mlig455_046761, Mlig455_046824 | Neo: - Age: Up-Down-Down Region-specific R8: 6.242 Region-enriched R8: 6.213/0.00000 Regeneration-downregulated BL: -5.695 Regeneration-depleted BL: -5.695 |
AVIL, VIL1 | 1.858 | - | - | - | - | 0.878 | 0.980 | Mlig455_046735 {REF} {Length: 3237} {TRANSSPLICED} {Pfam: Gelsolin repeat [PF00626.24, score=254.9]; Villin headpiece domain [PF02209.21, score=62.4]} {Human: ENSG00000135407, AVIL, advillin, [RH, Score=668, Expect=0.0]; ENSG00000127831, VIL1, villin 1, [RH, Score=656, Expect=0.0]} {Mouse: ENSMUSG00000025432, Avil, advillin, [RH, Score=655, Expect=0.0]} {Dmel: FBgn0010225, Gel, Gelsolin, [Score=339, Expect=4e-104]} {Celegans: WBGene00001443, fli-1, Protein flightless-1 homolog, [Score=157, Expect=3e-39]} {Smed: dd_Smed_v6_1215_0_1, dd_Smed_v6_1215_0_1, [Score=157, Expect=4e-42]} {RNA1509_17120} {RNA1310_1438.1} {RNA815_2416.1} Mlig455_046741 {REF} {Length: 3667} {Pfam: Gelsolin repeat [PF00626.24, score=257.0]; Villin headpiece domain [PF02209.21, score=62.3]} {Human: ENSG00000135407, AVIL, advillin, [RH, Score=690, Expect=0.0]; ENSG00000127831, VIL1, villin 1, [RH, Score=675, Expect=0.0]} {Mouse: ENSMUSG00000025432, Avil, advillin, [RH, Score=681, Expect=0.0]; ENSMUSG00000026175, Vil1, villin 1, [RH, Score=652, Expect=0.0]} {Dmel: FBgn0010225, Gel, Gelsolin, [Score=362, Expect=4e-113]} {Celegans: WBGene00010593, gsnl-1, Gelsolin-like protein 1, [Score=196, Expect=2e-54]} {Smed: dd_Smed_v6_929_0_1, dd_Smed_v6_929_0_1, [Score=179, Expect=1e-49]} {RNA1509_17120} {RNA1310_1438.1} {RNA815_5185} Mlig455_046761 {REF} {Length: 1969} {Pfam: Gelsolin repeat [PF00626.24, score=108.4]; Villin headpiece domain [PF02209.21, score=61.9]} {Human: ENSG00000127831, VIL1, villin 1, [Score=389, Expect=1e-130]; ENSG00000135407, AVIL, advillin, [Score=378, Expect=7e-123]} {Mouse: ENSMUSG00000026175, Vil1, villin 1, [Score=375, Expect=1e-121]; ENSMUSG00000025432, Avil, advillin, [Score=359, Expect=1e-115]} {Dmel: FBgn0003187, qua, quail, [Score=169, Expect=3e-45]} {Celegans: WBGene00010593, gsnl-1, Gelsolin-like protein 1, [Score=102, Expect=2e-23]} {Smed: dd_Smed_v6_1673_0_1, dd_Smed_v6_1673_0_1, [Score=104, Expect=2e-24]} {RNA1509_17120} {RNA1310_1438.1} {RNA815_2416.1} Mlig455_046824 {REF} {Length: 3159} {Pfam: Gelsolin repeat [PF00626.24, score=257.2]; Villin headpiece domain [PF02209.21, score=63.9]} {Human: ENSG00000135407, AVIL, advillin, [RH, Score=691, Expect=0.0]; ENSG00000127831, VIL1, villin 1, [RH, Score=674, Expect=0.0]} {Mouse: ENSMUSG00000025432, Avil, advillin, [RH, Score=682, Expect=0.0]; ENSMUSG00000026175, Vil1, villin 1, [RH, Score=652, Expect=0.0]} {Dmel: FBgn0010225, Gel, Gelsolin, [Score=365, Expect=3e-114]} {Celegans: WBGene00010593, gsnl-1, Gelsolin-like protein 1, [Score=192, Expect=3e-53]} {Smed: dd_Smed_v6_929_0_1, dd_Smed_v6_929_0_1, [Score=179, Expect=1e-49]} {RNA1509_17120} {RNA1310_1438.1} {RNA815_5185} |
93. | MligTC455_30812 | 30 | 0.62 | Mlig455_062785 | Neo: Irradiation Age: Down-Up-Down |
1.854 | 0.857 | - | - | - | - | 0.997 | Mlig455_062785 {REF} {Length: 4754} {RNA1509_43288} {RNA1310_42797} {RNA815_22641} | |
94. | MligTC455_16334 | 23 | 0.47 | Mlig455_048897 | Neo: - Age: - |
GABBR2 | 1.851 | - | - | - | 0.984 | 0.867 | - | Mlig455_048897 {REF} {Length: 2632} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=156.6]; Receptor family ligand binding region [PF01094.30, score=109.3]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=307, Expect=2e-91]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=306, Expect=2e-91]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=267, Expect=5e-76]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=234, Expect=4e-66]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=129, Expect=2e-33]} {RNA1509_38426} {RNA1310_30172} {RNA815_43578} |
95. | MligTC455_53657 | 221 | 4.6 | Mlig455_039396 | Neo: - Age: - Region-enriched R2: 6.078/0.00340 |
1.85 | - | 0.858 | - | 0.992 | - | - | Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004} | |
96. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 1.849 | - | 0.875 | - | - | 0.974 | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
97. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
1.848 | - | 0.859 | - | 0.989 | - | - | Mlig455_065030 {REF} {Length: 672} | |
98. | MligTC455_52165 | 671 | 13.99 | Mlig455_035531 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.972/0.00000 |
1.848 | - | - | - | 0.959 | 0.889 | - | Mlig455_035531 {REF} {Length: 648} {RNA1509_42191} {RNA1310_75398, RNA1509_42191} {RNA1509_42191, RNA815_40298} | |
99. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
1.847 | - | 0.872 | - | 0.975 | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
100. | MligTC455_00478 | 47 | 0.99 | Mlig455_067865 | Neo: - Age: - |
1.846 | 0.848 | - | - | - | - | 0.998 | Mlig455_067865 {REF} {Length: 684} |